| |
 |
|
Home > Medical Devices > Orthopedics > Global Orthopedics Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
|
Global Orthopedics Companies M&A, Joint Ventures, R&D Pipeline, and Strategies
|
 |
 |
 |
A strategic assessment of the competitive environment is unquestionably one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability. Timely and factual competitive intelligence is vital to the success of all business functions, especially Planning, Marketing, R&D and Manufacturing. In a highly dynamic and fragmented orthopedics market, besieged by intense competition, rapid pace of technological innovations and the uncertainty regarding future government regulations, the ability to anticipate new competitive product introductions and marketing strategies is particularly important... and can spell the difference between success and failure. The report is designed to provide the orthopedics industry executives with strategically significant competitor information, analysis and insight, critical to the development and implementation of effective marketing and R&D programs. The study's major objectives include: - To establish a comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world's leading orthopedics companies.
- To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis leading competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement organizations' internal competitor information gathering efforts by providing strategic analysis, data interpretation and insight.
- To identify market niches with significant growth potential.
Contains 620 pages and 55 tables
|
|
 |
| |
|
|
| |
|
|
|
Local PDF: $12500.00
Other Formats: Global PDF, DataPack
|
 |
| |
|
 |
| |
|
|
|